Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow A
Agilent Technologies, Inc. (A) Gross margin
Agilent Technologies, Inc.'s gross margin over the twelve months to 31 July 2026 was 53.8%, up 1.4 percentage points from fiscal 2025 (52.4%). Over the past ten years it has ranged from 50.5% (fiscal 2015) to 54.5% (fiscal 2018); the current reading is higher than 36% of that period. That is above the Diagnostics & Research industry median of 50.9% and in line with the Healthcare sector median of 53.5%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 52.4% | (1.87) |
| FY2024 | 54.3% | 3.59 |
| FY2023 | 50.7% | (3.64) |
| FY2022 | 54.4% | 0.43 |
| FY2021 | 53.9% | 0.78 |
| FY2020 | 53.1% | (1.19) |
| FY2019 | 54.3% | (0.21) |
| FY2018 | 54.5% | 0.90 |
| FY2017 | 53.6% | 1.36 |
| FY2016 | 52.3% | 1.74 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jul 2026 | 55.5% | 1.53 |
| Apr 2026 | 54.0% | 1.34 |
| Jan 2026 | 52.6% | (0.59) |
| Oct 2025 | 53.2% | 2.11 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ILMN Illumina, Inc. compare | 66.4% |
| NTRA Natera, Inc. compare | 65.2% |
| IDXX IDEXX Laboratories, Inc. compare | 62.5% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| A Agilent Technologies, Inc. | 53.8% |
| WAT Waters Corporation compare | 50.9% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| IQV IQVIA Holdings Inc. compare | 33.0% |
| LH Labcorp Holdings Inc. compare | 28.9% |
| Diagnostics & Research industry median | 50.9% |
| Healthcare sector median | 53.5% |
| Market median | 46.2% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on A
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement